Ph.D. Patrizia Cavazzoni: „Another potential tool in treating COVID-19 patients”
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric…